NeuroNexus Technologies and Philips partner to research deep brain stimulation devices
Philips, November 18, 2008
NeuroNexus Technologies and Philips Research have announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders. The two companies aim to show the technical feasibility of highly programmable and MRI-safe deep brain stimulation devices, according to a release. Their initial research will aim to meet the functional requirements of a deep brain stimulation device for the treatment of Parkinson?s disease.
- mHealth Tackles Readmissions
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Sharp HealthCare Leaves Pioneer ACO Program
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Proton Beam Therapy Poised for Growth in US
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013